Charles Schwab’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-18,803
| Closed | -$173K | – | 3583 |
|
|
2021
Q2 | $173K | Sell |
18,803
-77,623
| -81% | -$714K | ﹤0.01% | 3272 |
|
|
2021
Q1 | $480K | Hold |
96,426
| – | – | ﹤0.01% | 3090 |
|
|
2020
Q4 | $416K | Hold |
96,426
| – | – | ﹤0.01% | 3046 |
|
|
2020
Q3 | $414K | Sell |
96,426
-4,855
| -5% | -$20.8K | ﹤0.01% | 2927 |
|
|
2020
Q2 | $455K | Buy |
101,281
+4,326
| +4% | +$19.4K | ﹤0.01% | 2873 |
|
|
2020
Q1 | $388K | Buy |
96,955
+110
| +0.1% | +$440 | ﹤0.01% | 2797 |
|
|
2019
Q4 | $822K | Buy |
96,845
+9,902
| +11% | +$84K | ﹤0.01% | 2661 |
|
|
2019
Q3 | $596K | Hold |
86,943
| – | – | ﹤0.01% | 2733 |
|
|
2019
Q2 | $725K | Buy |
86,943
+7,742
| +10% | +$64.6K | ﹤0.01% | 2683 |
|
|
2019
Q1 | $727K | Buy |
79,201
+13,072
| +20% | +$120K | ﹤0.01% | 2647 |
|
|
2018
Q4 | $725K | Hold |
66,129
| – | – | ﹤0.01% | 2635 |
|
|
2018
Q3 | $923K | Buy |
66,129
+9,150
| +16% | +$128K | ﹤0.01% | 2651 |
|
|
2018
Q2 | $607K | Buy |
56,979
+14,879
| +35% | +$159K | ﹤0.01% | 2742 |
|
|
2018
Q1 | $365K | Hold |
42,100
| – | – | ﹤0.01% | 2819 |
|
|
2017
Q4 | $398K | Buy |
42,100
+6,600
| +19% | +$62.4K | ﹤0.01% | 2787 |
|
|
2017
Q3 | $279K | Hold |
35,500
| – | – | ﹤0.01% | 2906 |
|
|
2017
Q2 | $306K | Buy |
+35,500
| New | +$306K | ﹤0.01% | 2857 |
|
|
2015
Q3 | – | Sell |
-15,620
| Closed | -$107K | – | 3103 |
|
|
2015
Q2 | $107K | Sell |
15,620
-11,670
| -43% | -$79.9K | ﹤0.01% | 3043 |
|
|
2015
Q1 | $195K | Buy |
27,290
+14,390
| +112% | +$103K | ﹤0.01% | 2949 |
|
|
2014
Q4 | $97K | Sell |
12,900
-7,207
| -36% | -$54.2K | ﹤0.01% | 3064 |
|
|
2014
Q3 | $186K | Buy |
20,107
+403
| +2% | +$3.73K | ﹤0.01% | 2968 |
|
|
2014
Q2 | $368K | Buy |
+19,704
| New | +$368K | ﹤0.01% | 2763 |
|